Home > Healthcare > Biotechnology > Biotechnology R&D > Biological Sample Collection Kits Market

Biological Sample Collection Kits Market Share

Report ID: GMI6002
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Biological Sample Collection Kits Market Share

The market is experiencing significant growth due to rising global prevalence of respiratory disorders, fuelled by factors such as aging populations and lifestyle changes. Key players, including healthcare providers, and medical device manufacturers, drive innovation with technologies. Initiatives in collection kits, systems, consumables and personalized healthcare are reshaping the landscape, emphasizing early detection and tailored treatment approaches. As demand for accurate sample collection kits continues to escalate, market expansion, collaboration, and investment in advanced solutions are key strategies for industry players.

Biological Sample Collection Kits Market Companies

Prominent players operating in the biological sample collection kits industry include:

Abbott Laboratories
Altona Diagnostics GmbH
Becton, Dickinson and Company
CTK Biotech, Inc.
F. Hoffmann-La Roche Ltd
Hardy Diagnostics
HiMedia Laboratories
Laboratory Corporation of America Holdings
Lucence Health Inc.
Medline Industries, Inc.
Miraclean Technology Co. Ltd
Puritan Medical Products
QIAGEN
Seegene Inc.
Thermo Fisher Scientific, Inc.
VIRCELL S.L.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global biological sample collection kits industry was valued at USD 8.4 billion in 2023 and is expected to exhibit a CAGR of 8.8% from 2024 to 2032, driven by the increasing number of laboratory tests, fueled by rising chronic and infectious disease prevalence.

The hospitals and clinics segment is expected to grow at a pace of 8.7% between 2024-2032, as these settings experience a high volume of patient visits for a range of health issues, including acute and chronic conditions, routine check-ups, surgeries, and emergencies.

North America biological sample collection kits market accounted for USD 2.7 billion in 2023 and is anticipated to record a CAGR of 8.1% through 2032, owing to a high prevalence of chronic diseases, along with focus on regular monitoring and diagnostic testing.

Altona Diagnostics GmbH, Becton, Dickinson and Company, CTK Biotech, Inc., F. Hoffmann-La Roche Ltd, Hardy Diagnostics, HiMedia Laboratories, Laboratory Corporation of America Holdings, Lucence Health Inc., and Puritan Medical Products among others.